Literature DB >> 8924780

[The situation of dengue in the world].

F Rodhain1.   

Abstract

The situation of dengue in the world can be summarized as follows: 2,5 billions persons at risk, 60 millions cases per year, and 30 000 deaths per year. The four dengue serotypes, DEN-1, DEN-2, DEN-3 and DEN-4 are nearly human-specific. Clinical symptoms of dengue vary from unapparent infection, mild febrile manifestations to hemorrhagic forms with or without shock syndrome. Dengue viruses are transmitted by Aedes mosquitoes, the most important vectors being Aedes aegypti and Aedes albopictus. The epidemiology of the disease can be divided into endemo-epidemic situations occurring in South-East Asia, and epidemic situations found in Pacific islands, Africa and Tropical America. Maintenance of dengue is supported by an increasing demography, uncontrolled urbanization and climatic conditions favorable to the vectors. Spread of dengue is primarily caused by modern transportation means, especially the aircraft. The geographical distribution of dengue is pantropical, except for Madagascar and some african regions. Because no vaccine and no specific treatment actually exist against dengue viruses, mosquito control is the only way to reduce the incidence of dengue around the world. However, the evolution of the dengue situation is not satisfactory.

Entities:  

Mesh:

Year:  1996        PMID: 8924780

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  6 in total

Review 1.  Global change and human vulnerability to vector-borne diseases.

Authors:  Robert W Sutherst
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

2.  Clinical features, complications and atypical manifestations of children with severe forms of dengue hemorrhagic fever in South India.

Authors:  Shrishu R Kamath; Suchitra Ranjit
Journal:  Indian J Pediatr       Date:  2006-10       Impact factor: 1.967

3.  Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study.

Authors:  Rasel Ahmed Khan; Rajib Hossain; Abolghasem Siyadatpanah; Khattab Al-Khafaji; Abul Bashar Ripon Khalipha; Dipta Dey; Umma Hafsa Asha; Partha Biswas; Abu Saim Mohammad Saikat; Hadi Ahmadi Chenari; Polrat Wilairatana; Muhammad Torequl Islam
Journal:  Molecules       Date:  2021-11-11       Impact factor: 4.411

4.  The global distribution and burden of dengue.

Authors:  Samir Bhatt; Peter W Gething; Oliver J Brady; Jane P Messina; Andrew W Farlow; Catherine L Moyes; John M Drake; John S Brownstein; Anne G Hoen; Osman Sankoh; Monica F Myers; Dylan B George; Thomas Jaenisch; G R William Wint; Cameron P Simmons; Thomas W Scott; Jeremy J Farrar; Simon I Hay
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

5.  Evidence of dengue virus transmission and factors associated with the presence of anti-dengue virus antibodies in humans in three major towns in Cameroon.

Authors:  Maurice Demanou; Régis Pouillot; Marc Grandadam; Pascal Boisier; Basile Kamgang; Jean Pierre Hervé; Christophe Rogier; Dominique Rousset; Christophe Paupy
Journal:  PLoS Negl Trop Dis       Date:  2014-07-10

6.  Detection and serotyping of dengue viruses in febrile patients consulting at the New-Bell District Hospital in Douala, Cameroon.

Authors:  Francine Berlange Sado Yousseu; Fredy Brice Simo Nemg; Sandra Ateutchia Ngouanet; Franck Martin Obam Mekanda; Maurice Demanou
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.